Evidence map›Paper›PMID 25601634›Full record

ArticleGenes & nutrition2015

The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism.

Adam Kretowski, Edyta Adamska, Katarzyna Maliszewska, Natalia Wawrusiewicz-Kurylonek, Anna Citko, Joanna Goscik, Witold Bauer, Juliusz Wilk, Anna Golonko, Magdalena Waszczeniuk and 6 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Genes & nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03792685 (Analysis of Genetic Aspects of Metabolic Response on Diet With Different Content of Carbohydrate and Fat. Searching for Genetic Markers for Individualized Therapy in Patients With Obesity and Type 2 Diabetes), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03792685 nacompletednot on this map

Analysis of Genetic Aspects of Metabolic Response on Diet With Different Content of Carbohydrate and Fat. Searching for Genetic Markers for Individualized Therapy in Patients With Obesity and Type 2 Diabetes

TypeinterventionalSponsorMedical University of BialystokRan2009 to 2021Enrolled150ConditionsOverweight and Obesity, Diabetes Mellitus, Type 2, Metabolic Syndrome, Genetic PredispositionArmsNormo-carbohydrate meal intake, High-carbohydrate meal intake, High-fat meal intake, High-protein meal intake
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. KAmerican journal of physiology. Cell physiology · 2022
    Review
  10. Article
  11. Variants ofJournal of the Endocrine Society · 2022
    Article
  12. Dietary Fiber Intake May Influence the Impact ofAntioxidants (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. The Impact ofNutrients · 2020
    Article
  16. Two rare PROX1 variants in patients with lymphedema.Molecular genetics & genomic medicine · 2020
    Article
  17. Cell Fate Determination of Lymphatic Endothelial Cells.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Adam Kretowski *Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Edyta Adamska *Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Katarzyna MaliszewskaDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Natalia Wawrusiewicz-KurylonekDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Anna CitkoDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Joanna GoscikCentre for Experimental Medicine, Medical University of Bialystok, Bialystok, Poland.
Witold BauerDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Juliusz WilkDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Anna GolonkoDepartment of Dietetics and Nutrition, Medical University of Bialystok, Bialystok, Poland.
Magdalena WaszczeniukDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Danuta LipinskaDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Justyna HryniewickaDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Magdalena NiemiraClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Magdalena PaczkowskaClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Michal CiborowskiClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Maria GorskaDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M.C. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large-scale meta-analyses of genome-wide association studies have recently confirmed that the rs340874 single-nucleotide polymorphism in PROX1 gene is associated with fasting glycemia and type 2 diabetes mellitus; however, the mechanism of this link was not well established. The aim of our study was to evaluate the functional/phenotypic differences related to rs340874 PROX1 variants. The study group comprised 945 subjects of Polish origin (including 634 with BMI > 25) without previously known dysglycemia. We analyzed behavioral patterns (diet, physical activity), body fat distribution and glucose/fat metabolism after standardized meals and during the oral glucose tolerance test. We found that the carriers of the rs340874 PROX1 CC genotype had higher nonesterified fatty acids levels after high-fat meal (p = 0.035) and lower glucose oxidation (p = 0.014) after high-carbohydrate meal in comparison with subjects with other PROX1 genotypes. Moreover, in subjects with CC variant, we found higher accumulation of visceral fat (p < 0.02), but surprisingly lower daily food consumption (p < 0.001). We hypothesize that lipid metabolism alterations in subjects with the PROX1 CC genotype may be a primary cause of higher glucose levels after glucose load, since the fatty acids can inhibit insulin-stimulated glucose uptake by decreasing carbohydrate oxidation. Our observations suggest that the PROX1 variants have pleiotropic effect on disease pathways and it seem to be a very interesting goal of research on prevention of obesity and type 2 diabetes mellitus. The study may help to understand the mechanisms of visceral obesity and type 2 diabetes mellitus risk development.

Identifiers

PMID25601634
PMCPMC4298567
OpenAlexW2088546861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.